Head-to-head
Hims & Hers vs Sequence
Two opposite philosophies. Hims is a cash-pay drug-only path optimized for price. Sequence is an insurance-led, coaching-bundled program. They rarely fit the same patient.
Side-by-side
| Axis | Hims & Hers | Sequence |
|---|---|---|
| Cash starting price | $149/mo | N/A — insurance-led |
| Insurance acceptance | None | Most commercial + Medicaid in covered states |
| Coaching | None | Assigned coach + WW behavioral content |
| Speed to first dose | Within days | Within 1-2 weeks (insurance approval) |
- Cash starting price: Sequence is not designed for cash-pay; if you have no insurance, Hims is the path.
- Insurance acceptance: If your plan covers GLP-1s, you leave money on the table going cash-pay.
- Coaching: Strong factor if behavior change is your real lever.
- Speed to first dose: Hims is faster to start; Sequence is slower but cheaper long-term with insurance.
Bottom line
Pick Hims & Hers if
You're cash-pay, want to start fast, and coaching is not your priority.
See Hims & Hers reviewPick Sequence if
You have commercial insurance and want a coach. The combination is what Sequence is built for.
See Sequence reviewAffiliate links. Glpverdict may earn a commission when you sign up. Our editorial ranking is independent — see how we rank.
Other head-to-head comparisons